NCT02737228 2019-06-17
Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
CrystalGenomics, Inc.
Phase 1/2 Unknown
Clinical Trials
4 trialsNCT02906163 2016-09-19
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
SciClone Pharmaceuticals
Phase 1/2 Unknown
NCT02146118 2014-05-23
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma
MedicalLogic
Phase 2 Unknown
NCT00591383 2012-07-19
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
Alaunos Therapeutics
Phase 1 Unknown